Active Ingredient(s): Oxymetazoline Hydrochloride
FDA Approved: * January 18, 2017
Pharm Company: * ALLERGAN INC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Rhofade Overview

Oxymetazoline is a selective α1 adrenergic receptor agonist and α2 adrenergic receptor partial agonist. It is a topical decongestant, used in the form of oxymetazoline hydrochloride. It was developed from xylometazoline at E. Merck Darmstadt by Fruhstorfer in 1961.[1] Oxymetazoline is generally available as a nasal spray. Contents 1 Medical uses 2 Side effects and special considerations 2.1 Rebound congestion 2.2 Effects of benzalkonium chloride 2.3 Use in pregnancy 3 Over...

Read more Rhofade Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oxymetazoline

Recent Rhofade Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Oxymetazoline Hydrochloride
  • Cream: 1%
  • Solution: 0.025%, 0.05%
  • Solution/drops: 0.025%, 0.03%
  • Spray: 0.05%
  • Spray, Metered: 0.025%, 0.05%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rhofade: (1 result)

Sorted by National Drug Code
  • 0023-5300 Rhofade 10 mg/g Topical Cream by Allergan

Other drugs which contain Oxymetazoline Hydrochloride or a similar ingredient: (20 results)